We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Announces Advancement of RNAi Therapeutic Development Program

News   Apr 18, 2007

 
Alnylam Announces Advancement of RNAi Therapeutic Development Program
 
 
 

RELATED ARTICLES

Targeted Therapy Proves Effective Against Aggressive Blood Cancer in Clinical Trial

News

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN).

READ MORE

How "Bad Cholesterol" Enters Artery Walls to Drive Plaque Development

News

UT Southwestern researchers have determined how circulating “bad cholesterol” enters artery walls to cause the plaque that narrows the blood vessels and leads to heart attacks and strokes.

READ MORE

Exposing and Exploiting Cancer’s Metabolic Addictions

News

Where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE